Introduction

Material and methods Results
A total of 25,367 patients with TBC were identified; 9.2% of them had also a diagnosis of DM2 (Figure 1 ). Patients with DM 2 had a higher mortality than non-DM patients (7.7 % vs 4.8 %; p<0.01) (Figure 2 ). Hypoglycaemia was registered in 150 cases, also associated with higher mortality. 
Conclusions
• In our study, TBC patients admitted to Spanish hospitals in the presence of DM2 and also those with hypoglycaemia showed an increased mortality.
• The extra-pulmonary and spread forms are also relatively frequent (>30%) in subjects with DM2.
• Early screening of DM2 and/or treatment with tight glycemic control in individuals hospitalized for TBC might be able to decrease the mortality associated in patients with both diagnoses on admission.
• Patients with diabetes with a poor treatment adherence and a HbA1C >6% could be a risk group for developing TBC, probably due to the long term immunosuppressive state thus generated.
• Recent studies indicate that the coexistence of DM and TB alters the distribution of the cell populations in the immune system, although large cross-sectional trials are required. 
